30 September 2022
GENEVA - The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has formally launched the process for selecting its next Chair and Vice-Chair for a 3-year term from 2023-2026, to succeed the current Board Leadership, whose terms expire in May 2023. The role of Chair is currently held by Dr. Donald Kaberuka, and that of the Vice-Chair by Lady Roslyn Morauta. The Board Chair and Vice-Chair act as ambassadors and advocates for the Global Fund’s work and lead the Board, which determines the Global Fund’s strategy and policies.
The Chair and Vice-Chair will be responsible for guiding the deliberations of a Board comprised of an extraordinarily diverse mix of stakeholders and partners. Both will be figures of real stature and will have track records of accomplishment that equip them to serve the Global Fund in its strategic deliberations and in its communication to external partners. The Board Leadership will bring deep experience of working with multistakeholder governance bodies. Between them, the Chair and Vice-Chair will possess an understanding of the global public health architecture and of the governance process of the Global Fund, as well as transferrable leadership experience from other sectors.
The Global Fund’s Board includes 20 voting members, with equal representation of implementers and donors. Non-governmental organizations, the private sector, private foundations, and communities affected by HIV, TB and malaria are also represented as voting members. In addition, there are eight non-voting members, including the Board Chair and Vice-Chair, representatives of partner organizations including the World Health Organization, UNAIDS and the World Bank, and the Additional Public Donors constituency.
The Global Fund has retained Russell Reynolds Associates to assist with these appointments. For further information on the positions and additional details on qualifications, requirements, terms and conditions of service and how to express interest, please see here.